ELOX

Q: What is the price of Eloxx Pharmaceuticals (ELOX) today?

The current price of Eloxx Pharmaceuticals (ELOX) is $ 0.11, representing a 109900% gain over the past year. The stock began the year trading around $ 0.000100 and is currently priced at $ 0.11. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Eloxx Pharmaceuticals (ELOX) pay dividends?

Eloxx Pharmaceuticals (ELOX) did not pay dividends over the past year.

Eloxx Pharmaceuticals Inc.

Price

$ 0.11

return (12m)

109,900.00% Logo

p/e

-0.20

p/bv

-0.15

DIVIDEND YIELD

0.00%

ELOX price

ELOX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ELOX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

10.00%

3 months

109,900.00%

1 year

109,900.00%

2 years

-88.57%

5 years

-99.88%

10 years

-99.94%

Fundamentals ELOX

review the fundamentals of Eloxx Pharmaceuticals shares

P/E

-0.20

Sector: -2.14 Industry: 10.87

P/S (PSR)

Sector: 1.94 Industry: 1.57

P/BV

-0.15

Sector: 2.13 Industry: 3.07

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: 0.01%

ROA

-174.74%

Sector: -25.39% Industry: 2.70%

ROE

77.32%

Sector: -29.75% Industry: 5.25%

ROIC

0.00%

Sector: -418.64% Industry: -2.27%

NET MARGIN

0.00%

Sector: -27.73% Industry: 2.71%

GROSS MARGIN

0.00%

Sector: 44.91% Industry: 28.76%

OPERATING MARGIN

0.00%

Sector: -22.84% Industry: 1.39%

EV/EBITDA

-0.21

Sector: -0.35 Industry: 3.98

EV/EBIT

-0.20

Sector: -1.68 Industry: 2.39

PRICE-TO-ASSETS

0.34

Sector: 1.14 Industry: 1.42

BVPS

-0.99

Sector: 3.83 Industry: 11.41

EPS

-0.77

Sector: -0.89 Industry: 1.09

EQUITY-TO-ASSETS RATIO

-2.26

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

3.26

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-5.30%

Sector: - Industry: -

Fundamentals ELOX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	41.59	35.99	86.53%	0.65%	$ 858.38 B	31.66%
ISRG	56.96	9.07	15.92%	0.00%	$ 162.68 B	28.38%
TMO	27.82	3.48	12.52%	0.35%	$ 186.54 B	15.05%
SNY	12.68	1.38	10.86%	4.67%	$ 115.62 B	18.68%
NVS	21.29	6.40	30.04%	4.48%	$ 297.73 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.58	2.30	9.38%	2.41%	$ 113.37 B	13.00%
GSK	15.39	5.50	35.71%	3.00%	$ 117.42 B	17.48%
CVS	56.86	1.33	2.35%	3.36%	$ 100.53 B	0.44%
BSX	31.39	0.00	0.00%	0.00%	$ 90.98 B	14.44%
TMDX	19.73	7.94	40.22%	0.00%	$ 3.75 B	31.43%
HCA	17.15	-41.99	-244.82%	0.58%	$ 116.34 B	8.97%
IDXX	44.22	29.19	65.99%	0.00%	$ 46.85 B	24.62%
RMD	22.49	5.29	23.51%	1.02%	$ 33.42 B	27.53%
DHR	38.03	2.62	6.88%	0.66%	$ 137.43 B	14.71%
INMD	9.25	1.27	13.73%	0.00%	$ 868.14 M	25.32%
PHG	25.94	2.09	8.06%	3.13%	$ 26.91 B	5.07%
FMS	11.96	0.81	6.75%	3.34%	$ 13.50 B	5.02%
SYK	40.02	5.79	14.48%	1.00%	$ 129.89 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ELOX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Eloxx Pharmaceuticals

Eloxx Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

27 years

Founded: 1999

1998

Time since IPO - 28 years

25

Employees

Eloxx Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.80 Million, with shareholders equity totaling $-11.91 Millions.

The company employs approximately 25 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Eloxx Pharmaceuticals Inc. reported $- in revenue, generating net income of $-9.21 Millions.

Key financial metrics include a P/E ratio of -0.20, a price-to-book (P/B) ratio of -0.15, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ELOX.

Market cap

$ 1.80 Million

Net worth

$ -11.91 Millions

$ -11,910,000.00

Assets

$ 5.27 Millions

$ 5,270,000.00

Total Shares Outstanding

12.00 Millions

12,000,000

Average Daily Trading Volume

$ 7.68 Thousand

$ 7,680.18

Sector

Health

Industry

Pharmaceutical Products

ELOX

ELOX revenue and profits

Financial Results ELOX

DRAG THE FRAME TO SEE MORE DATA

ELOX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.30 20,27% (12M)

P/E

56.86

3.36%

ROE

2.35%

P/BV

1.33

CI - Cigna

$ 278.64 --13,81% (12M)

P/E

10.78

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 38.17 --37,12% (12M)

P/E

-2.75

0.00%

ROE

-33.28%

P/BV

0.91

HUM - Humana

$ 205.14 --20,95% (12M)

P/E

19.94

1.79%

ROE

6.70%

P/BV

1.34

HCA - HCA Healthcare

$ 488.00 46,66% (12M)

P/E

17.15

0.58%

ROE

-244.82%

P/BV

-41.99

LLY - Eli Lilly

$ 927.03 14,15% (12M)

P/E

41.59

0.65%

ROE

86.53%

P/BV

35.99

NVS - Novartis

$ 151.97 44,80% (12M)

P/E

21.29

4.48%

ROE

30.04%

P/BV

6.40